New designs for the selection of treatments to be tested in randomized clinical trials

Richard Simon, Peter F. Thall, Susan S. Ellenberg

Type: Review

Publication Date: 1994-03-15

Citations: 53

DOI: https://doi.org/10.1002/sim.4780130506

View Publication

Locations

PubMed - View
Statistics in Medicine - View

Similar Works

Action	Title	Year	Authors
+	Design Issues of Randomized Phase II Trials and a Proposal for Phase II Screening Trials	2005	Larry Rubinstein Edward L. Korn Boris Freidlin Sally Hunsberger S. Percy Ivy Malcolm A. Smith
+	General statistical design considerations of randomized clinical trials.	1988	Peter Peduzzi
+	Designs for efficient clinical trials.	1989	Richard H. Simon
+	New designs for phase 2 clinical trials	2003	Elihu H. Estey Peter F. Thall
+ PDF Chat	Design Issues in Randomized Phase II/III Trials	2012	Edward L. Korn Boris Freidlin Jeffrey S. Abrams Susan Halabi
+	Randomized phase II clinical trials.	1985	Richard Simon R. Wittes Susan S. Ellenberg
+	Phase III Trials	2012	Garnet L. Anderson Michael LeBlanc P.Y. Liu John J. Crowley
+	Sample sizes for phase II and phase III clinical trials: An integrated approach	1986	John Whitehead
+ PDF Chat	Phase II Clinical Trial Design: Methods in Translational Research from the Genitourinary Committee at the Eastern Cooperative Oncology Group	2006	Robert J. Gray Judith Manola Scott Saxman James R. Wright J. P. Dutcher Michael B. Atkins Michael Carducci William A. See Christopher J. Sweeney Glenn Liu
+ PDF Chat	Design of phase II oncology trials evaluating combinations of experimental agents	2023	Elad Sharon Jared C. Foster
+	Phase II Trials	2012	Stephanie Green
+	Randomized Phase II Designs	2023	Haitao Pan Ying Yuan
+	The design of phase II trials	1989	Michael Cullen
+	New Designs for Clinical Trials	2007	Elihu H. Estey
+ PDF Chat	Design and Analysis of Phase II Clinical Trials	1997	Sin‐Ho Jung Byung‐Joo Park Min-Joo Sohn Ji Yun Kim
+	A two-stage design for choosing among several experimental treatments in phase III clinical trials	1987
+	Design of Phase II Trials	2018	Hongkun Wang Gina R. Petroni
+	17 Early Phase Clinical Trials: Phases I and II	2007	Feng Gao Kathryn Trinkaus J. Philip Miller
+	Phase II Trials	2004	Keith T. Flaherty Peter J. O’Dwyer
+	Designs Using Time-to-Event Endpoints/Single-Arm versus Randomized Phase II Designs	2012	Catherine M. Tangen John Crowley

Works That Cite This (29)

Action	Title	Year	Authors
+ PDF Chat	Bayesian statistics in medicine: a 25 year review	2006	Deborah Ashby
+	Selection Bias in Clinical Trials With Antipsychotics	2000	Alex Hofer Martina Hummer Regina Huber Martin Kurz T. Walch W. Wolfgang Fleischhacker
+ PDF Chat	Speeding up the Evaluation of New Agents in Cancer	2008	Mahesh Parmar F. M.- S. Barthel Matthew R. Sydes Ruth E. Langley Richard Kaplan E. Eisenhauer Mark F. Brady Nicholas D. James Michael A. Bookman Ann Marie Swart
+	Understanding the FDA Guidance on Adaptive Designs: Historical, Legal, and Statistical Perspectives	2010	Qing Liu Y. H. George
+ PDF Chat	A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity	2011	Peter F. Thall Hoang Q. Nguyen Xuemei Wang Johannes Wolff
+	THE ATTRACTIVENESS OF THE CONCEPT OF A PROSPECTIVELY DESIGNED TWO-STAGE CLINICAL TRIAL	1999	Y. H. George Qing Liu
+ PDF Chat	Novel Methodologic Approaches to Phase I, II, and III Trials	2013	Sharon D. Yeatts
+ PDF Chat	Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma	2008	Josep M. Llovet Adrian M. Di Bisceglie Jordi Bruix Barnett S. Kramer Riccardo Lencioni Andrew X. Zhu Morris Sherman Myron Schwartz Michael T. Lotze Jayant A. Talwalkar
+	A study design with conditional, serially assessed co‐primary endpoints: An application to a single‐arm, pilot non‐Hodgkin's lymphoma trial	2010	Jonathan D. Mahnken Jo Wick Byron J. Gajewski Matthew S. Mayo
+ PDF Chat	Bayesian methods in health technology assessment: a review.	2000	Spiegelhalter Myles Jones Keith R. Abrams

Works Cited by This (12)

Action	Title	Year	Authors
+	Optimal two-stage screening designs for survival comparisons	1990	Daniel J. Schaid Sam Wieand Terry M. Therneau
+	A two-stage design for randomized trials with binary outcomes	1987	Sam Wieand Terry M. Therneau
+	A sequential phase II/III trial for binary outcomes	1990	Barry E. Storer
+	Controlled Studies in Clinical Cancer Research	1972	Thomas C. Chalmers Jerome B. Block Stephanie J. Lee
+	Two-stage selection and testing designs for comparative clinical trials	1988	Peter F. Thall Richard Simon Susan S. Ellenberg
+	A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials	1989	Peter F. Thall Richard Simon Susan S. Ellenberg
+	Calibrated phase II clinical trials in oncology	1986	Jay Herson Stephen K. Carter
+	Optimal two‐stage designs for clinical trials with binary response	1988	Peter F. Thall Richard Simon Susan S. Ellenberg Richard I. Shrager
+	Incorporating historical control data in planning phase II clinical trials	1990	Peter F. Thall Richard Simon
+	Randomized phase II clinical trials.	1985	Richard Simon R. Wittes Susan S. Ellenberg